4
Changes in Ownership
Harmony Biosciences Holdings, Inc. Filed Acc 0000899243-21-035508
Chief Commercial Officer sold 5,000 shares at $37.00 ($185,000)
- Chief Commercial Officer acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dierks Jeffrey Chief Commercial Officer | 2021-09-07 | Option exercise | +5,000 | $8.22 | $41,100 | 5,000 | D: show line 1 in the form |
| Dierks Jeffrey Chief Commercial Officer | 2021-09-07 | Sale | −5,000 | $37.00 | $185,000 | 0 | D: show line 2 in the form |
| Open-market sales · 5,000 sh · avg $37.00 · $185,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dierks Jeffrey Chief Commercial Officer | 2021-09-07 | Option exercise · Stock Option | −4,083 | 7,304 | D: show line 3 in the form | ||
| Dierks Jeffrey Chief Commercial Officer | 2021-09-07 | Option exercise · Stock Option | −917 | 23,428 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…